IL5 and coronary artery disorder: Figure 2 shows exploratory subgroup analyses with the OR of CHD for the top versus the bottom third of IL-6, IL-5, IFN-γ, TNF-α, IL-6R and CRP in all participants and in the subsets of participants who were non-users of statins or non-users of aspirin therapy at the time of recruitment.